Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP372265.RAYFp1P9TUQwdhLHf7w-bZXVNtHteqkhsxDC91EDurHJw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP372265.RAYFp1P9TUQwdhLHf7w-bZXVNtHteqkhsxDC91EDurHJw130_assertion type Assertion NP372265.RAYFp1P9TUQwdhLHf7w-bZXVNtHteqkhsxDC91EDurHJw130_head.
- NP372265.RAYFp1P9TUQwdhLHf7w-bZXVNtHteqkhsxDC91EDurHJw130_assertion description "[The mTOR effectors 4EBP1 and S6K2 are frequently coexpressed, and associated with a poor prognosis and endocrine resistance in breast cancer: a retrospective study including patients from the randomised Stockholm tamoxifen trials.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP372265.RAYFp1P9TUQwdhLHf7w-bZXVNtHteqkhsxDC91EDurHJw130_provenance.
- NP372265.RAYFp1P9TUQwdhLHf7w-bZXVNtHteqkhsxDC91EDurHJw130_assertion evidence source_evidence_literature NP372265.RAYFp1P9TUQwdhLHf7w-bZXVNtHteqkhsxDC91EDurHJw130_provenance.
- NP372265.RAYFp1P9TUQwdhLHf7w-bZXVNtHteqkhsxDC91EDurHJw130_assertion SIO_000772 24131622 NP372265.RAYFp1P9TUQwdhLHf7w-bZXVNtHteqkhsxDC91EDurHJw130_provenance.
- NP372265.RAYFp1P9TUQwdhLHf7w-bZXVNtHteqkhsxDC91EDurHJw130_assertion wasDerivedFrom befree-20150227 NP372265.RAYFp1P9TUQwdhLHf7w-bZXVNtHteqkhsxDC91EDurHJw130_provenance.
- NP372265.RAYFp1P9TUQwdhLHf7w-bZXVNtHteqkhsxDC91EDurHJw130_assertion wasGeneratedBy ECO_0000203 NP372265.RAYFp1P9TUQwdhLHf7w-bZXVNtHteqkhsxDC91EDurHJw130_provenance.